Ameriprise’s Tarsus Pharmaceuticals TARS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $354K | Sell |
8,740
-50,174
| -85% | -$2.03M | ﹤0.01% | 3610 |
|
|
2025
Q1 | $3.03M | Buy |
58,914
+11,229
| +24% | +$577K | ﹤0.01% | 2655 |
|
|
2024
Q4 | $2.64M | Buy |
47,685
+8,336
| +21% | +$462K | ﹤0.01% | 2758 |
|
|
2024
Q3 | $1.29M | Sell |
39,349
-8,799
| -18% | -$289K | ﹤0.01% | 3099 |
|
|
2024
Q2 | $1.31M | Sell |
48,148
-10,219
| -18% | -$278K | ﹤0.01% | 3045 |
|
|
2024
Q1 | $2.12M | Buy |
58,367
+4,917
| +9% | +$179K | ﹤0.01% | 2840 |
|
|
2023
Q4 | $1.08M | Buy |
53,450
+145
| +0.3% | +$2.94K | ﹤0.01% | 3154 |
|
|
2023
Q3 | $947K | Buy |
53,305
+37,430
| +236% | +$665K | ﹤0.01% | 3168 |
|
|
2023
Q2 | $287K | Buy |
+15,875
| New | +$287K | ﹤0.01% | 3620 |
|